Hepion Pharmaceuticals (HEPA) Stock Statistics & Valuation Metrics

Hepion Pharmaceuticals has a market cap or net worth of $755.32K. The enterprise value is ―.

Hepion Pharmaceuticals has 11,620,317 shares outstanding. The number of shares has decreased by -2.65% in one year.

Hepion Pharmaceuticals’s return on equity (ROE) is 7.08 and return on invested capital (ROIC) is -1152.89%.

The current PE Ratio of Hepion Pharmaceuticals is ―. Hepion Pharmaceuticals’s PEG ratio is 0.00265.

In the last 12 months, Hepion Pharmaceuticals had revenue of 0.00 and earned -13.19M in profits. Earnings per share was -107.35.

In the last 12 months, operating cash flow was -4.09M and capital expenditures 0.00, giving a free cash flow of -4.09M billion.

Hepion Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Hepion Pharmaceuticals upcoming earnings date is ―, ―.

Hepion Pharmaceuticals as a current ratio of 0.51, with Debt / Equity ratio of 9.79%

In the past 12 months, Hepion Pharmaceuticals has paid -2.97M in taxes.

Hepion Pharmaceuticals EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -0.30.

Hepion Pharmaceuticals has $2.32M in cash and marketable securities with $214.31K in debt, giving a net cash position of $2.11M billion.

Gross margin is 50.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Hepion Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―